Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Claire Rothery"'
Autor:
Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Publikováno v:
Health Technology Assessment, Vol 28, Iss 73 (2024)
Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volum
Externí odkaz:
https://doaj.org/article/15cd75425bbc4dfdace72310b07f0618
Autor:
Edward Cox, Ros Wade, Robert Hodgson, Helen Fulbright, Thai Han Phung, Nicholas Meader, Simon Walker, Claire Rothery, Mark Simmonds
Publikováno v:
Health Technology Assessment, Vol 28, Iss 30 (2024)
Background Parkinson’s disease is a brain condition causing a progressive loss of co ordination and movement problems. Around 145,500 people have Parkinson’s disease in the United Kingdom. Levodopa is the most prescribed treatment for managing mo
Externí odkaz:
https://doaj.org/article/622770438be64f26883bc4f10dab7464
Autor:
Beth Woods, Laetitia Schmitt, Dina Jankovic, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark Sculpher, Sue Harnan
Publikováno v:
Health Technology Assessment, Vol 28, Iss 28 (2024)
Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volum
Externí odkaz:
https://doaj.org/article/df351dc2cd9242afbdd0e0a130f560e2
Autor:
Lindsay Claxton, Mark Simmonds, Lucy Beresford, Richard Cubbon, Mark Dayer, Stephen S Gottlieb, Nick Hartshorne-Evans, Bruce Kilroy, Alexis Llewellyn, Claire Rothery, Sahar Sharif, Jayne F Tierney, Klaus K Witte, Kath Wright, Lesley A Stewart
Publikováno v:
Health Technology Assessment, Vol 26, Iss 4 (2022)
Background: Chronic heart failure is a debilitating condition that accounts for an annual NHS spend of £2.3B. Low levels of endogenous coenzyme Q10 may exacerbate chronic heart failure. Coenzyme Q10 supplements might improve symptoms and slow progre
Externí odkaz:
https://doaj.org/article/b151c5176c8c45e09fa4005ddb878ab4
Autor:
Ana Duarte, Alexis Llewellyn, Ruth Walker, Laetitia Schmitt, Kath Wright, Simon Walker, Claire Rothery, Mark Simmonds
Publikováno v:
Health Technology Assessment, Vol 25, Iss 56 (2021)
Background: QAngio® XA 3D/QFR® (three-dimensional/quantitative flow ratio) imaging software (Medis Medical Imaging Systems BV, Leiden, the Netherlands) and CAAS® vFFR® (vessel fractional flow reserve) imaging software (Pie Medical Imaging BV, Maa
Externí odkaz:
https://doaj.org/article/06cac2dc63c543c99e265a69c22fef79
Autor:
Karl Claxton, Beth Woods, Claire Rothery, Paul Revill, Timothy B Hallett, Andrew Phillips, Laetitia Schmitt
Publikováno v:
BMJ Global Health, Vol 5, Iss 8 (2020)
Introduction We present practical metrics for estimating the expected health benefits of specific research proposals. These can be used by research funders, researchers and healthcare decision-makers within low-income and middle-income countries to s
Externí odkaz:
https://doaj.org/article/94c84642f9074fe7ad4886492d7d65ca
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 16, Iss 1, Pp 1-14 (2018)
Abstract Background Fenestrated endovascular aneurysm repair (fEVAR) is a new approach for complex abdominal aortic aneurysms, limited to a few specialist centers, with limited evidence base. We developed a cost-effectiveness decision model of fEVAR
Externí odkaz:
https://doaj.org/article/162cd6ba7be84192be76a5eb2f103ab0
Autor:
Ana Duarte, Teumzghi Mebrahtu, Pedro Saramago Goncalves, Melissa Harden, Ruth Murphy, Stephen Palmer, Nerys Woolacott, Mark Rodgers, Claire Rothery
Publikováno v:
Health Technology Assessment, Vol 21, Iss 64 (2017)
Background: Psoriasis is a chronic inflammatory disease that predominantly affects the skin. Adalimumab (HUMIRA®, AbbVie, Maidenhead, UK), etanercept (Enbrel®, Pfizer, New York, NY, USA) and ustekinumab (STELARA®, Janssen Biotech, Inc., Titusville
Externí odkaz:
https://doaj.org/article/61c05baaf6734bcf9ec732def98145a4
Autor:
Simon Walker, Ruth Walker, Laetitia Schmitt, Kath Wright, Ana Duarte, Claire Rothery, Alexis Llewellyn, Mark Simmonds
Publikováno v:
Health Technology Assessment, Vol 25, Iss 56 (2021)
Background QAngio® XA 3D/QFR® (three-dimensional/quantitative flow ratio) imaging software (Medis Medical Imaging Systems BV, Leiden, the Netherlands) and CAAS® vFFR® (vessel fractional flow reserve) imaging software (Pie Medical Imaging BV, Maas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82ac59696d96dbf0370f00c9565b407
https://doi.org/10.3310/hta25560
https://doi.org/10.3310/hta25560
Autor:
Natalia Kunst, Christopher Jackson, Claire Rothery, Haitham Tuffaha, Stephen Birch, Mark Strong
Publikováno v:
Appl Health Econ Health Policy
Value-of-information analysis (VOI) is a decision-theoretic approach that is used to inform reimbursement decisions, optimise trial design and set research priorities. The application of VOI analysis for informing policy decisions in practice has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85df44c20985b8ac95723e1091fe5d36
https://doi.org/10.1007/s40258-021-00662-4
https://doi.org/10.1007/s40258-021-00662-4